4 things about mRNA COVID vaccines researchers still want to find out

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 February 4 things about mRNA COVID vaccines researchers still want to find out 4 things about mRNA COVID vaccines researchers still want to find out 08/02/2021 | 3 MINS This article by Associate Professor Archa Fox from LIT's School of Molecular Sciences and Harry Al-Wassiti from Monash University originally appeared in The Conversation on 2 February 2021. The first mRNA vaccines approved for use in humans ΓÇö the Pfizer/BioNTech and Moderna COVID-19 vaccines ΓÇö are being rolled out around the world. These vaccines deliver mRNA, coated in lipid (fat), into cells. Once inside, your body uses instructions in the mRNA to make SARS-CoV-2 spike proteins. The immune response protects around 95% of people vaccinated with either vaccine from developing COVID-19. Such mRNA vaccines have many benefits. They are quick to design, so once the manufacturing platform is set up, mRNA vaccines can be designed to target different viruses, or variants, very quickly. The vaccine manufacturing is also fully synthetic, and doesnΓÇÖt rely on living cells like ch

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 February 4 things about mRNA COVID vaccines researchers still want to find out 4 things about mRNA COVID vaccines researchers still want to find out 08/02/2021 | 3 MINS This article by Associate Professor Archa Fox from LIT's School of Molecular Sciences and Harry Al-Wassiti from Monash University originally appeared in The Conversation on 2 February 2021.

The first mRNA vaccines approved for use in humans ΓÇö the Pfizer/BioNTech and Moderna COVID-19 vaccines ΓÇö are being rolled out around the world.

We do more when we ask better questions together.